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To the Editor
I deeply regret to inform you and request for retraction of 
our review paper published in YMJ.1 
We have applied for the U.S. patent with some ideas and re-
search data which are related to the review paper. Upon re-
quest from a patent lawyer’s office, we checked the refer-
ences used in our paper for the Information Disclosure 
Statement (IDS). We realized that our review paper plagia-
rized several sentences from a previously published review 
paper titled as “The biochemical and biological functions of 
human papillomavirus type 16 E5 protein” in Arch Virol 
(2003;148:1445-53). As a corresponding author, I will take 
full responsibility and respectfully request for the retraction 
of our review paper from YMJ.
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